In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Loxo Oncology at Lilly
For over 50 years, Lilly has been dedicated to delivering life-changing medicines to people living with cancer. Lilly is determined to continue making life better for all those affected by cancer. In 2019 Lilly created Loxo Oncology at Lilly, with the goal of rapidly delivering impactful new medicines for patients. Our approach centers on creating new medicines that unequivocally work in early clinical development and will matter to patients.
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
Educational Grant Sponsors
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies and has several products being developed in collaboration with leading pharmaceutical companies. Astex is a member of the Otsuka group of pharmaceutical companies which also includes Taiho Pharmaceutical and Taiho Oncology.
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
GSK is focused on maximising patient survival through transformational medicines. Our goal is to achieve a sustainable flow of new treatments in immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality.
At Janssen Oncology, our purpose is to make cancer a manageable and, ultimately, curable condition. We understand that the power to change the lives of those living with cancer begins with a very considered step forwards. Whether it’s from finding novel solutions, a new indication approval, or even just reaching one more patient. That’s The Power of Purpose™.
For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.